Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
⚠️ Amphotericin B binds to fungal ergosterol but also interacts with human cholesterol → explaining its major toxicities, especially nephrotoxicity. 💊 Liposomal amphotericin B (Ambisome® or equivalent generic) is the preferred formulation in the UK: far less nephrotoxic and better tolerated than conventional amphotericin B deoxycholate. 👨⚕️ Use only under specialist guidance, with strict dosing and monitoring protocols.
| Formulation / Context | Recommended Dosing Information |
|---|---|
| 💊 Liposomal Amphotericin B (Ambisome® / Generic) |
• 3–5 mg/kg/day IV infusion over ≥2 hours.
• Use only 5% dextrose for dilution (incompatible with saline). • No test dose required (unlike conventional amphotericin). • Adjust per infection type and response. |
| 💊 Conventional Amphotericin B Deoxycholate
(rarely used in UK) |
• 0.25–1 mg/kg/day IV in 5% dextrose.
• Test dose: 1 mg in 20 mL 5% dextrose over 20–30 min. • ⚠️ Fatal overdose if >1.5 mg/kg/day. |
| 💊 Amphotericin B Lipid Complex (Abelcet®) |
• 5 mg/kg/day IV.
• Withdrawn from UK market in 2023; retained in some EU/US centres. |